In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2023 ASCO Annual Meeting in breast cancer, lymphoma, multiple myeloma, brain tumors, and von Hippel-Lindau syndrome.
Dr. Amar Kelkar and Dr. Vincent Ho discuss what people with cancer and their caregivers should know about recovery in the weeks and months after a bone marrow transplant, including what follow-up care will be needed, what symptoms may occur, and how daily life may change.
The ASCO Annual Meeting is being held June 2 to 6. A study presented today shows that removing radiation therapy from the treatment plan for an aggressive form of lymphoma does not impact the risk of recurrence or overall survival.
The ASCO Annual Meeting is being held June 2 to 6. Several notable studies will be presented today. Topics include radiation therapy in rectal cancer, osimertinib for lung cancer, vorasidenib for grade 2 glioma, nivolumab for Hodgkin lymphoma, and mirvetuximab soravtansine for ovarian cancer.
Cancer survivor Devorah Aschendorf discusses what it was like being diagnosed with an aggressive form of lymphoma while pregnant, how she coped with caring for a newborn during cancer treatment, and how this experience changed her perspective on life.
In this podcast, Dr. Christopher Flowers discusses new research from the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition, including new treatments for non-Hodgkin lymphoma and models for predicting early disease progression.
Radiation oncologist and cancer survivor Dr. Arthur Hamberger shares how being diagnosed with cancer led him to a career in oncology, what it was like being diagnosed with multiple cancers 45 years later, and his advice on coping with a cancer diagnosis.
In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma.
In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma.
